Correlation Between Milestone Pharmaceuticals and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Milestone Pharmaceuticals and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and NLS Pharmaceutics.
Diversification Opportunities for Milestone Pharmaceuticals and NLS Pharmaceutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and NLS is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and NLS Pharmaceutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.63 times more return on investment than NLS Pharmaceutics. However, Milestone Pharmaceuticals is 1.59 times less risky than NLS Pharmaceutics. It trades about 0.3 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.08 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 43.00 from holding Milestone Pharmaceuticals or generate 29.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| NLS Pharmaceutics |
Milestone Pharmaceuticals and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and NLS Pharmaceutics
The main advantage of trading using opposite Milestone Pharmaceuticals and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.The idea behind Milestone Pharmaceuticals and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |